11:00am ET - 11:30am ET
Fireside Chat with John Carroll
An in-depth discussion featuring Endpoints Editor-in-chief John Carroll and professor and director of the Merkin Institute at the Broad Institute David R. Liu
John Carroll
Editor & Founder
Endpoints News
David R. Liu
Richard Merkin Professor and Director of the Merkin Institute at the Broad Institute of MIT and Harvard
Broad Institute, Harvard University, and HHMI
11:00am ET - 12:00am ET
The heat is on to find new ways to advance preclinical drug research
As a new law takes effect aimed at reducing animal testing, Endpoints gathers together a core group of drug discovery experts to explore the real world challenges involved in shifting away from well established animal research practices while simultaneously attempting to streamline projects as demands on nonhuman primate work intensifies.
Amber Roberts
Senior Vice President
Pioneering Medicines at Flagship Pioneering
Amber Roberts
Senior Vice President
Pioneering Medicines at Flagship Pioneering
Amber Roberts
Senior Vice President
Pioneering Medicines at Flagship Pioneering
David R. Liu
Richard Merkin Professor and Director of the Merkin Institute at the Broad Institute of MIT and Harvard
Broad Institute, Harvard University, and HHMI
moderator
11:30am ET - 12:30pm ET
The heat is on to find new ways to advance preclinical drug research
As a new law takes effect aimed at reducing animal testing, Endpoints gathers together a core group of drug discovery experts to explore the real world challenges involved in shifting away from well established animal research practices while simultaneously attempting to streamline projects as demands on nonhuman primate work intensifies.
David Grainger
Chief Innovation Officer
Centessa Pharmaceuticals
John E. Connolly
Chief Scientific Officer
Parker Institute for Cancer Immunotherapy (PICI)
Peter Emtage
CEO Santa Ana Bio
Versant Ventures
Lorna Ewart
Chief Scientific Officer
Emulate
Rachel Lane
Principal
Versant Ventures
John Carroll
Editor & Founder
Endpoints News
moderator
